Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $156,271 | 78 | 74.6% |
| Food and Beverage | $31,044 | 1,224 | 14.8% |
| Travel and Lodging | $18,313 | 106 | 8.7% |
| Education | $3,550 | 15 | 1.7% |
| Consulting Fee | $420.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $67,066 | 203 | $0 (2024) |
| ABBVIE INC. | $44,611 | 145 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $37,422 | 121 | $0 (2024) |
| Allergan, Inc. | $16,842 | 70 | $0 (2020) |
| Takeda Pharmaceuticals America, Inc. | $13,590 | 43 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $13,441 | 208 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $4,109 | 226 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $2,731 | 60 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $2,195 | 70 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,542 | 52 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,696 | 206 | Alkermes, Inc. ($18,550) |
| 2023 | $44,437 | 212 | AbbVie Inc. ($26,264) |
| 2022 | $27,917 | 227 | Alkermes, Inc. ($20,589) |
| 2021 | $23,661 | 225 | Alkermes, Inc. ($10,970) |
| 2020 | $7,071 | 127 | Allergan, Inc. ($2,839) |
| 2019 | $20,281 | 120 | Otsuka America Pharmaceutical, Inc. ($11,825) |
| 2018 | $28,947 | 137 | Otsuka America Pharmaceutical, Inc. ($10,564) |
| 2017 | $29,587 | 171 | Takeda Pharmaceuticals America, Inc. ($13,590) |
All Payment Transactions
1,425 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: CNS | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: CNS | ||||||
| 12/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.22 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: CNS | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Neuropsychiatry | ||||||
| 11/27/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $760.00 | General |
| Category: CNS | ||||||
| 11/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: CNS | ||||||
| 11/19/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,060.00 | General |
| Category: CNS | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $37.99 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Central Nervous System | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $1.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 31 | 243 | $36,450 | $15,318 |
| 2022 | 1 | 30 | 278 | $41,700 | $18,585 |
| 2021 | 2 | 53 | 263 | $40,060 | $16,911 |
| 2020 | 2 | 62 | 336 | $52,130 | $16,247 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 243 | $36,450 | $15,318 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 278 | $41,700 | $18,585 | 44.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 205 | $30,780 | $14,946 | 48.6% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 24 | 58 | $9,280 | $1,964 | 21.2% |
| 90832 | Psychotherapy, 30 minutes | Office | 2020 | 29 | 173 | $27,680 | $9,087 | 32.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 163 | $24,450 | $7,160 | 29.3% |
About Dr. David Stein, M.D
Dr. David Stein, M.D is a Psychiatry healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740386341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Stein, M.D has received a total of $209,598 in payments from pharmaceutical and medical device companies, with $27,696 received in 2024. These payments were reported across 1,425 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($156,271).
As a Medicare-enrolled provider, Stein has provided services to 176 Medicare beneficiaries, totaling 1,120 services with total Medicare billing of $67,060. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Honolulu, HI
- Active Since 09/15/2006
- Last Updated 10/06/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1740386341
Products in Payments
- LYBALVI (Drug) $64,214
- VRAYLAR (Drug) $61,341
- REXULTI (Drug) $38,358
- Trintellix (Drug) $21,849
- LATUDA (Drug) $4,109
- INGREZZA (Drug) $2,731
- CAPLYTA (Drug) $2,139
- ARISTADA (Drug) $1,873
- INVEGA SUSTENNA (Drug) $1,419
- TRINTELLIX (Drug) $1,395
- AUSTEDO (Drug) $1,297
- Aristada 441 mg (Drug) $828.80
- ABILIFY MAINTENA (Drug) $557.00
- UZEDY (Drug) $463.66
- Austedo XR (Drug) $434.39
- SPRAVATO (Drug) $318.12
- Auvelity (Drug) $291.48
- BRINTELLIX (Drug) $228.10
- Dayvigo (Drug) $224.07
- VYVANSE (Drug) $203.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Honolulu
Dr. Denis Mee-Lee, Md, MD
Psychiatry — Payments: $520,826
Dr. Peter Dee, Md, MD
Psychiatry — Payments: $59,404
Dr. Jon Cooney, Md, MD
Psychiatry — Payments: $24,667
Dr. Gregory Yuen, M.d, M.D
Psychiatry — Payments: $7,901
Raymond Davidson, M.d, M.D
Psychiatry — Payments: $5,748
Dr. Alan Buffenstein, M.d, M.D
Psychiatry — Payments: $3,826